WPATH Admits Its Gender Guidelines Are Not Based on Medical Facts
The global body behind the guidelines used in Australia's gender clinics has told a US court its “Standards of Care” are opinion, not medical fact.
WPATH's Confession
On the 28th of July 2026, the World Professional Association for Transgender Health (WPATH) asked a US federal court to throw out a Federal Trade Commission lawsuit, joined by four state attorneys-general, accusing it of deceptive trade practices over its Standards of Care, the guidelines underpinning youth gender medicine across the Western world. WPATH's defence was remarkable. It told the court its own treatment standards are “non-actionable opinions” on a subject of ongoing scientific uncertainty, not factual claims a regulator has any business testing.
This is the same organisation whose guidelines have been marketed to Australian hospitals, insurers and governments for a decade as a settled, evidence-based standard of care. Parents and clinicians who questioned that “consensus” were routinely told the science was settled. WPATH has now told a federal court, under oath, that its standard of care was in fact not settled science, but an opinion.
Australia's Guidelines Rest on the Same “Opinion”
Every public gender clinic in Australia operates under the 2018 Australian Standards of Care and Treatment Guidelines. These guidelines were written by the Royal Children's Hospital and modelled directly on WPATH's Standards of Care and the equivalent guideline from the US Endocrine Society.
It was never fit for purpose. When the UK's Cass Review commissioned an independent, university-led appraisal of gender clinic guidelines from around the world, Australia's document scored just 19 out of 100 for rigour of development and 14 out of 100 for editorial independence. It was not recommended for use. A peer-reviewed Australian analysis reached the same conclusion the following year: our guidelines share the same weak foundations as WPATH's, and are not fit for clinical practice.
Every Warning Butler Chose to Ignore
The Federal Minister for Health, Mark Butler, cannot say he didn't know. In November 2022, his own department and parliamentary adviser scrambled to head off a proposed Senate inquiry into puberty blockers, working from a brief headed “Possible harm caused to trans kids through public inquiries.” In April 2024, the UK's four-year Cass Review found the evidence for puberty blockers too weak to justify routine use; the National Health Service ended routine prescribing within days.
January 2025 alone brought two more warnings. Queensland paused all new hormone treatment for minors after reports that children as young as 12 had been given cross-sex hormones without authorised care. And more than 100 doctors, psychiatrists, lawyers and academics, including former Prime Minister Tony Abbott, wrote to Canberra demanding a full independent public inquiry and an immediate pause on treatment for under-18s. Butler gave them neither. Instead, he announced a $2 million review by the National Health and Medical Research Council (NHMRC), not a public inquiry, and, according to his own Assistant Minister, little more than an “update” of guidelines already found unfit for use.
Eighteen months later, the NHMRC's own published timeline confirms interim advice on puberty blockers, the single priority item of the entire project, is not due for public release until the end of August 2026. The full guideline will not be finalised until March 2028: more than three years after Butler ordered it, and almost four years after the world was first told these drugs were not safe to be routinely prescribed.
Also read: South Australia Moves to Protect Children From Irreversible Puberty Blockers
Adelaide Is What That Delay Looks Like
As Family in Danger reported in July 2026, the Women's and Children's Hospital in Adelaide admitted that 22 children, one just 11 years old, were approved for hormone treatment between July 2023 and July 2024 without the psychiatric assessment its own guidelines require. Hospital network CEO Rebecca Graham apologised, conceding the clinic's “model of care was not strictly followed,” and commissioned a review, promising findings within months.
More than a year later, SA Health confirmed it intends to keep that review's findings a secret. A state health department investigating why 22 children missed a mandatory safeguard is refusing to show its findings to the families it concerns, let alone the taxpayers who fund the clinic. This is not an isolated incident. In 2023, independent MP Frank Pangallo tried to secure a South Australian parliamentary inquiry into gender dysphoria care. He withdrew the motion in 2024 once Labor, the Greens and a Liberal crossbencher all confirmed they would vote it down.
Butler Had Every Warning. He Chose Delay.
None of this happened in the dark. Butler had the Cass Review, his own department's 2022 warnings, Queensland's pause, a public letter signed by a former Prime Minister, and now WPATH's own admission, under oath, that the “science” behind Australia's guidelines was never more than one side's opinion. Faced with all of it, he chose the slower process over the honest one, then let even that process run past its own deadlines. Twenty-two South Australian children have already paid for that choice. Their own families are now being told they can't see what went wrong. What is it going to take for Australia to join the rest of the world and stop putting children in danger?
What You Can Do
State and federal governments have made accessing common-sense health care for gender-confused children illegal and have mandated the “affirmation” model, which has been coming under increased scrutiny. The best way to change this is to sign our petition to make common-sense therapies based on biological reality legal again. You can help us by signing the petition here.
References
- WPATH, motion to dismiss, FTC v. WPATH, US District Court, filed 28 July 2026
- Royal Children's Hospital Melbourne, Australian Standards of Care and Treatment Guidelines for Trans and Gender Diverse Children and Adolescents, Version 1.4, 2023
- Systematic guideline appraisal commissioned for the Cass Review (University of York AGREE II assessment), cited in Clayton A, Amos AJ, Spencer J, Clarke P, “Implications of the Cass Review for health policy governing gender medicine for Australian minors,” Australasian Psychiatry, February 2025
- Clayton A, Amos AJ, Spencer J, Clarke P, “Implications of the Cass Review for health policy governing gender medicine for Australian minors,” Australasian Psychiatry, February 2025
- Internal departmental correspondence and briefing documents, obtained under Freedom of Information law and cited in Bernard Lane, “Mark Butler did it,” Gender Clinic News, April 2024
- SBS News, “Government announces federal review into gender-affirming healthcare for young people,” 31 January 2025
- Letter to Prime Minister Anthony Albanese, 29 January 2025; reported in Medical Republic, “Butler orders NHMRC review of gender-affirming care for kids,” 31 January 2025
- The Hon Mark Butler MP, ministerial statement, 31 January 2025; Ged Kearney MP, public statement, 31 January 2025
- National Health and Medical Research Council, “Guideline development process for the care of trans and gender diverse people under 18 with gender dysphoria,” nhmrc.gov.au, accessed 17 August 2026
- Women's and Children's Hospital Network, CEO Rebecca Graham, public statement, cited 4 April 2025
- Adelaide Now / The Advertiser, “SA Health buries review after 22 kids miss gender psych checks”
- Family in Danger, “South Australia Moves to Protect Children From Irreversible Puberty Blockers,” 13 July 2026